Medicine Park

Results: 1689



#Item
31Intersect ENT Recognized for Gender Diversity by Watermark and UC Davis Company Also Recognized in Deloitte’s 2015 Technology Fast 500 MENLO PARK, Calif., November 17, 2015 – Intersect ENT, Inc. (Nasdaq:XENT), a comp

Intersect ENT Recognized for Gender Diversity by Watermark and UC Davis Company Also Recognized in Deloitte’s 2015 Technology Fast 500 MENLO PARK, Calif., November 17, 2015 – Intersect ENT, Inc. (Nasdaq:XENT), a comp

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2015-11-17 11:28:47
32Intersect ENT Announces Data Further Demonstrating Health Economic Value of PROPEL Steroid Releasing Implants Savings Associated with Reduced Post-Operative Interventions Support Use of PROPEL MENLO PARK, Calif., Novembe

Intersect ENT Announces Data Further Demonstrating Health Economic Value of PROPEL Steroid Releasing Implants Savings Associated with Reduced Post-Operative Interventions Support Use of PROPEL MENLO PARK, Calif., Novembe

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2015-11-10 10:16:52
33Water Safety for Children by John Voth, MD Family Medicine Specialist, Colorado Springs Health Partners, PC  Summertime means fun at the pool, the lake, and the water park.

Water Safety for Children by John Voth, MD Family Medicine Specialist, Colorado Springs Health Partners, PC Summertime means fun at the pool, the lake, and the water park.

Add to Reading List

Source URL: www.cshpkids.net

Language: English - Date: 2010-09-21 14:46:53
    34Intersect ENT Announces NUB Status 1 Designation for PROPEL Sinus Implant in Germany Decision Represents Early Step in Building the Company’s Foundation Internationally MENLO PARK, Calif.—January 29, 2016—Intersect

    Intersect ENT Announces NUB Status 1 Designation for PROPEL Sinus Implant in Germany Decision Represents Early Step in Building the Company’s Foundation Internationally MENLO PARK, Calif.—January 29, 2016—Intersect

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2016-02-02 07:14:47
    35Factswww.iastate.edu  People

    Factswww.iastate.edu People

    Add to Reading List

    Source URL: web.iastate.edu

    Language: English - Date: 2016-02-22 11:59:38
    36Intersect ENT Enrolls First Patient in Pivotal Study to Evaluate the NOVA Sinus Implant Novel Device May Broaden Patient Population for Steroid Releasing Implants Menlo Park, Calif. – July 8, 2015 – Intersect ENT, In

    Intersect ENT Enrolls First Patient in Pivotal Study to Evaluate the NOVA Sinus Implant Novel Device May Broaden Patient Population for Steroid Releasing Implants Menlo Park, Calif. – July 8, 2015 – Intersect ENT, In

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2015-07-08 11:49:34
    37Intersect ENT Announces Positive Preliminary Clinical Results for the PROPEL Mini Steroid Releasing Implant in Patients with Frontal Sinus Disease Menlo Park, Calif. – August 17, 2015 – Intersect ENT, Inc. (Nasdaq:XE

    Intersect ENT Announces Positive Preliminary Clinical Results for the PROPEL Mini Steroid Releasing Implant in Patients with Frontal Sinus Disease Menlo Park, Calif. – August 17, 2015 – Intersect ENT, Inc. (Nasdaq:XE

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2015-08-17 10:01:39
    38Medicine Beyond Medication: The Heart of the Matter Frederik Meijer Gardens & Sculpture Park | Grand Rapids, MI Friday, October 24, :55 PM  Registration Opens

    Medicine Beyond Medication: The Heart of the Matter Frederik Meijer Gardens & Sculpture Park | Grand Rapids, MI Friday, October 24, :55 PM Registration Opens

    Add to Reading List

    Source URL: www.uhsmi.com

    Language: English
      39® 66 t BLAKE STREET  HADLEY DRIVE

      ® 66 t BLAKE STREET HADLEY DRIVE

      Add to Reading List

      Source URL: www.dhtraining.org

      Language: English - Date: 2015-07-21 19:47:23
      40Intersect ENT Announces FDA Submission to Seek Expanded Indication of PROPEL Mini Steroid Releasing Implant to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—September 29, 2015—Intersect ENT, Inc. (Nasd

      Intersect ENT Announces FDA Submission to Seek Expanded Indication of PROPEL Mini Steroid Releasing Implant to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—September 29, 2015—Intersect ENT, Inc. (Nasd

      Add to Reading List

      Source URL: propelopens.com

      Language: English - Date: 2015-09-29 20:19:21